Infinite CBD Oil

Because CBD can be seen as part of the cannabis industry, Infinite CBD knew they had an uphill battle to show their customers they are trustworthy and reputable. Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products Are you looking for high-quality CBD isolates? Infinite CBD is one of our preferred providers. Click here to learn more about Absolute Zero CBD Isolates.

How Infinite CBD is converting 7.1% more visitors into buyers

“With much uncertainty in the Cannabis/CBD industry, implementing the Norton Shopping Guarantee allows us the opportunity to increase customer confidence and satisfaction.”

Stephen Ryan, Owner Infinite CBD

Dedicated to improving the world’s quality of life with a natural substance our bodies are built to consume, Infinite CBD was born. Their dream is to educate the public on CBD’s medical benefits and provide high quality, affordable products for better health. Instead of using CBD oil as many suppliers do, Infinite CBD chose to use a superior CBD isolate with terpenes to produce higher quality products. They sell products ranging from topical creams to capsules, and edible gummies to soap, for any type of injury or ailment.

Aside from providing high quality and affordable products, Infinite CBD truly cares about CBD users and the CBD industry as a whole. To do so, they provide education on the human endocannabinoid system and how CBD works directly within this part of the body to help you achieve homeostasis.

Infinite CBD tells the stories of their shoppers whose lives have improved greatly after using Infinite CBD products. From curing insomnia and anxiety to reducing joint pain and inflammation, CBD can do it all. Infinite CBD tells these stories because they’re not just about selling products, but about changing the lives of their shoppers.

Because CBD can be seen as part of the cannabis industry, Infinite CBD knew they had an uphill battle to show their customers they are trustworthy and reputable, and that their products do not contain THC. They knew that one way to better improve shopper confidence and instill trust would be to utilize a shopping guarantee. They found Norton Shopping Guarantee to be the best option that was low maintenance and high reward.

Infinite Product Company LLLP DBA Infinite CBD MARCS-CMS 593175 — November 22, 2019

This letter is to advise you that the Food and Drug Administration (FDA) reviewed your website at the Internet address www.infinitecbd.com in September 2019 and has determined that you take orders there for the products “Absolute Zero 99% + CBD Isolate,” “Freezing Point CBD Topical Cream,” “Afterglow Healing Oil 100 mg CBD Total,” “Nano Enhancer Pure Nano CBD,” “Nano Freezing Point CBD Topical Cream,” “Asteroid Gummies,” “Sour Asteroid Gummies,” “Sweetened Dropper,” and “Nano Non Dairy Creamer,” all of which you promote as products containing cannabidiol (CBD). We have also reviewed your social media websites at https://www.facebook.com/infinitecbd/ and https://www.instagram.com/infinite_c_b_d/; these websites direct consumers to your website http://www.infinitecbd.com to purchase your products. The claims on your website and social media websites establish that the above-named products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore, these products are misbranded drugs under section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1). FDA has also determined that you take orders for the products “Pet Droppers” and “Launch Pad” on your website at www.infinitecbd.com. These products, which you promote as products containing CBD, are unapproved new animal drugs that are unsafe under section 512(a) of the FD&C Act, 21 U.S.C. 360b(a), and adulterated under section 501(a)(5) of the FD&C Act, 21 U.S.C. 351(a)(5).

As explained further below, introducing or delivering these products for introduction into interstate commerce violates the FD&C Act. You can find the FD&C Act and FDA regulations through links on FDA’s home page at www.fda.gov. You can find specific information about how FDA regulates CBD at https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd.

The Agency is particularly concerned that you market one of your unapproved new drug products, “Asteroid Gummies,” for children. Specifically, your website states that consumers can give the product “as a treat to your kid[.]” Your product has not been evaluated by the Agency for safety, effectiveness, and quality. The use of untested drugs can have unpredictable and unintended consequences, especially in vulnerable populations. For example, children may be at greater risk for adverse reactions associated with certain drug products due to differences in the ability of children to absorb, metabolize, distribute, or excrete such drug products or their metabolites.

Unapproved New Drugs

Based on our review of your websites, your “Absolute Zero 99%+ CBD Isolate,” “Freezing Point CBD Topical Cream,” “Afterglow Healing Oil 100mg CBD Total,” “Nano Enhancer Pure Nano CBD,” “Nano Freezing Point CBD Topical Cream” “Asteroid Gummies,” “Sour Asteroid Gummies,” “Sweetened Dropper,” and “Nano Non Dairy Creamer” products are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body.

Examples of claims observed on your website www.infinitecbd.com that establish the intended use of your products as drugs include, but may not be limited to, the following:

On your product webpage for “Freezing Point CBD Topical Cream”:

  • “Freezing Point Cream[.] Freeze away all aches and pains. [P]ainkiller and muscle relaxant.”

On your product webpage for “Afterglow Healing Oil 100mg CBD Total”:

  • “Great for new tattoos, eczema, psoriasis, acne, scarring, or open wounds.”

On your product webpage for “Nano Freezing Point CBD Topical Cream”:

  • “Instantly eliminate aches and pains with NANO CBD Pain Cream . Reduce pain and inflammation associated with conditions like arthritis, osteoarthritis, and muscle injury.”

On your webpage titled “A Guide to Hepatitis and CBD”:

  • “Can CBD Alleviate Symptoms of Hepatitis. CBD can positively impact those with hepatitis C…It is clear that CBD’s potential for helping those with hepatitis is there…”

On your webpage titled “Autism and the Endocannabinoid System”:

  • “CBD Can Alleviate Some Symptoms of Autism.”

On your webpage titled “CBD as a Potential Treatment Method for Tourette Syndrome”:

  • “Cannabinoids Reduce Tourette Syndrome Symptoms…CBD can treat severe motor and vocal tics related to TS. Therefore, more and more TS patients are trying cannabinoids as an alternative treatment method.”

On your webpage titled “World Cancer Day: How CBD Helps Cancer”:

  • “How CBD Helps Cancer…Using biological pathways, cannabinoids (like CBD) have been found to target and inhibit the growth of cancer cells.”
  • “A more specific examination of this shows that CBD has anti-angiogenic properties when applied to a variety of tumors.”
  • “A study published in early 2017 demonstrated that CBD improved the chances of survival in patients with aggressive brain cancers.”
  • “A study on lung cancers published in 2012 suggests that CBD ‘decreases cancer cell invasiveness.’ By acting to increase tissue inhibitor in particular molecules in the lungs, CBD acts to reduce the spread of cancerous cells.”

On your webpage titled “Uses of CBD?”:

  • “Mad cow disease…Substance abuse disorders…Cancer…Diabetes…”
  • “Neuroprotective: with regards to conditions such as Parkinson’s and Alzheimer’s, both studies have shown CBD to work against the toxicity in the neurons of the brain, working as an antioxidant and providing protection against further deterioration.”
  • “Anti-cancer: CBD has shown to be effective in blocking and preventing further growth of cancer cells within the body.”
  • “Mad Cow Disease – the prion is the agent responsible for causing neurodegenerative disease. With CBD, production of this agent is blocked.”

On your webpage “Should I Use CBD Versus Opioids”:

  • “CBD – Natural and Safe Alternative to Opioids…Also due to opioids’ addictiveness and painful withdrawal symptoms, people have moved towards using CBD as their primary treatment method.”

Additional claims observed on your social media sites include, but are not limited to, the following:

On your Facebook page at https://www.facebook.com/infinitecbd:

  • (posted May 25, 2018) “‘[C]annabinoids have been tested in several experimental models of autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, colitis and hepatitis and have been shown to protect the host from the pathogenesis…’”

On your Instagram page at https://www.instagram.com/infinite_c_b_d:

  • (posted June 21, 2019) “Oxidative stress can trigger serious health issues, like cancer, heart disease, and Alzheimer’s. CBD is a patented neuroprotective antioxidant.”
  • (posted August 16, 2019) “Infinite CBD was born out of the success of helping someone suffering from Lymes [sic] Disease. After taking CBD, the individual stated that he has become ‘the most pain free’ he had ever been”
See also  CBD Oil Side Effects Heart Palpitations

Your “Absolute Zero 99%+ CBD Isolate,” “Freezing Point CBD Topical Cream,” “Afterglow Healing Oil 100mg CBD Total,” “Nano Enhancer Pure Nano CBD,” “Nano Freezing Point CBD Topical Cream,” “Asteroid Gummies,” “Sour Asteroid Gummies,” “Sweetened Dropper,” and “Nano Non Dairy Creamer” products are not generally recognized as safe and effective for their above referenced uses and,therefore, these products are “new drugs” under section 201(p) of the FD&C Act, 21 U.S.C. 321(p). New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA, as described in sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a). FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. There are no FDA-approved applications in effect for any of the above mentioned products.

Misbranded Drugs

Your “Absolute Zero 99%+ CBD Isolate,” “Freezing Point CBD Topical Cream,” “Afterglow Healing Oil 100mg CBD Total,” “Nano Enhancer Pure Nano CBD,” “Nano Freezing Point CBD Topical Cream,” “Asteroid Gummies,” “Sour Asteroid Gummies,” “Sweetened Dropper,” and “Nano Non Dairy Creamer,” products are also misbranded within the meaning of section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1), in that their labeling fails to bear adequate directions for use. “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended. (See 21 CFR 201.5.) The aforementioned products are offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners; therefore, adequate directions for use cannot be written so that a layperson can use these drugs safely for their intended purposes. FDA approved prescription drugs that bear their FDA-approved labeling are exempt from the requirements that they bear adequate directions for use by a layperson. However, your products are not exempt from the requirement that their labeling bear adequate directions for use, under 21 CFR 201.100(c)(2) and 201.115, because no FDA approved applications are in effect for them. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the FD&C Act, 21 U.S.C. 331(a).

301(ll) and Adulterated Human Foods

We note that your Asteroid Gummies,” “Sour Asteroid Gummies,” “Sweetened Dropper,” and “Nano Non Dairy Creamer” products appear to be promoted as conventional human food. For example, your labeling describes the products, variously, as “delicious,” “tasty treat[]”, “sweetened flavor,” and something that can be “[e]asily tossed into your lunch” or added to beverages. However, you should be aware that it is a prohibited act under section 301(ll) of the FD&C Act, 21 U.S.C. 331(ll), to introduce or deliver for introduction into interstate commerce any food to which has been added a drug approved under section 505 of the FD&C Act or for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public,. FDA has concluded that the prohibition in section 301(ll) applies to CBD.1 There is an exception if the substance was marketed in food before the drug was approved or before the substantial clinical investigations involving the drug had been instituted. However, based on available evidence, FDA has concluded that this is not the case for CBD. FDA is not aware of any evidence that would call into question its current conclusion that section 301(ll) of the FD&C Act, 21 U.S.C. 331(ll), prohibits the introduction into interstate commerce of any food to which CBD has been added, but you may present FDA with any evidence bearing on this issue.

You should also be aware that, as defined in section 201(s) of the FD&C Act (21 U.S.C. 321(s)), the term “food additive” refers to any substance the intended use of which results in its becoming a component of any food, unless the substance is generally recognized as safe (GRAS) among qualified experts under the conditions of its intended use, or unless the substance meets a listed exception.2

Food additives require premarket approval based on data demonstrating safety. Any food additive that has not been approved for its intended use in food is deemed to be unsafe under section 409(a) of the FD&C Act (21 U.S.C. 348(a)), and causes the food to be adulterated under section 402(a)(2)(C)(i) of the FD&C Act, 21 U.S.C. 342(a)(2)(C)(i). Introduction of an adulterated food into interstate commerce is prohibited under section 301(a) of the FD&C Act, 21 U.S.C. 331(a).

There is no food additive regulation which authorizes the use of CBD. We are not aware of any information to indicate that CBD is the subject of a prior sanction (see 21 CFR Part 181). Furthermore, we are not aware of any basis to conclude that CBD is GRAS for use in conventional foods. FDA’s regulations in 21 CFR 170.30(a)-(c) describe the criteria for eligibility for classification of a food ingredient as GRAS. The use of a food substance may be GRAS based on either scientific procedures or, for a substance used in food before 1958, through experience based on common use in food (see 21 CFR 170.30).

We know of no basis for general recognition of safety for CBD based either on scientific procedures or common use in food prior to January 1, 1958. Based on our review of published, scientific literature, existing data and information do not provide an adequate basis to conclude that the use of CBD in food meets the criteria for GRAS status. Many unanswered questions and data gaps about CBD toxicity exist, and some of the available data raise serious concerns about potential harm from CBD. Our review of publicly available data associated with the one FDA-approved CBD drug, as well as our review of published scientific literature, identified potential for liver injury from CBD and potentially harmful interactions with certain drugs. In addition, studies in animals have shown that CBD can interfere with the development and function of testes and sperm, decrease testosterone levels, and impair sexual behavior in males. Therefore, based on our review, the use of CBD in conventional food products does not satisfy the criteria for GRAS status under 21 CFR 170.30.

FDA is not aware of any other exception to the food additive definition that would apply to CBD for use as an ingredient in a conventional food. Therefore, CBD added to a conventional food is a food additive under section 201(s) of the FD&C Act and is subject to the provisions of section 409 of the FD&C Act. Under section 409, a food additive is deemed unsafe unless it is approved by FDA for its intended use prior to marketing. CBD is not approved for use in any conventional food. Food containing an unsafe food additive within the meaning of section 409 is adulterated within the meaning of section 402(a)(2)(C)(i) of the FD&C Act. Introduction of an adulterated food into interstate commerce is prohibited under section 301(a) of the FD&C Act, 21 U.S.C. 331(a).

Unapproved New Animal Drugs

During our review of your firm’s website https://infinitecbd.com/shop/, FDA determined that your firm is marketing the unapproved new animal drugs “Pet Droppers” and “Launch Pad.” Based on our review of your website, your “Pet Droppers” and “Launch Pad” products are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals and/or intended to affect the structure or any function of the body of animals. Further, as discussed below, these products are unapproved new animal drugs and marketing them violates the FD&C Act.

Examples of claims observed on your website https://infinitecbd.com/shop/ that establish the intended use of your products as drugs include, but may not be limited to, the following:

On your product webpage for “Pet Droppers

  • “The combination of coconut oil allows for a healthier coat, clears up eczema, reduces allergies, improves digestion, and aids in arthritis and ligament problems.”
  • From product Reviews: “Infinite CBD, 09/26/19

Thank you for sharing your pup’s CBD experience with us! We are thrilled to hear how well our Pet Droppers are helping with their separation anxiety. The combination of coconut oil and CBD also promotes a healthier coat, pain and inflammation relief, and improves digestion. We appreciate your feedback and look forward to doing business with you again soon!”

  • “Infinite CBD, 09/18/19
See also  Can You Give Dogs Human CBD Oil

Hi Helen,
Thank you for your review of our Pet Droppers! We are thrilled to hear how well this product is helping to relieve insomnia and anti inflammatory issues. We appreciate your feedback and we look forward to doing business with you again soon!”

On your product webpage for “Launch Pad

CBD Isolate –… With the anti-inflammatory properties of CBD Isolate, this can help ease the irritation of chapped/dry skin as well as wounds.

MCT Oil – Famous for anti-aging properties, Vitamin E & A content, improving skin elasticity and collagen production and overall hydration.

Beeswax – Assists with anti-inflammatory and antibacterial properties while protecting against external irritants.

Mango Butter – Traditionally used to treat eczema and psoriasis, this butter provides fatty acids and antioxidants.

Sunflower Oil – Famous for the potential of reducing scar tissue, sunflower oil helps maintain skin health by supplying necessary nutrients and copious vitamin E.

Rosemary – Has the potential to protect skin cells from damage often caused by the sun and free radicals.”

Your “Pet Droppers” and “Launch Pad” products are not generally recognized as safe and effective for the above referenced uses and, therefore, these products are “new animal drugs” under section 201(v) of the FD&C Act, 21 U.S.C. 321(v). To be legally marketed, a new animal drug must have an approved new animal drug application, conditionally approved new animal drug application, or index listing under sections 512, 571, and 572 of the FD&C Act, 21 U.S.C. 360b, 360ccc, and 360ccc-l. These products are not approved or index listed by the FDA, and therefore these products are considered unsafe under section 512(a) of the FD&C Act, 21 U.S.C. 360b(a), and adulterated under section 501(a)(5) of the FD&C Act, 21 U.S.C. 351(a)(5). Introduction of these adulterated drugs into interstate commerce is prohibited under section 301(a) of the FD&C Act, 21 U.S.C. 331(a).

301(ll) and Adulterated Animal Foods

Moreover, to the extent that you market any of your products containing CBD as animal food, you should be aware that it is a prohibited act under section 301(ll) of the FD&C Act, 21 U.S.C. 331(ll), to introduce or deliver for introduction into interstate commerce any animal food to which has been added a drug approved under section 505 of the FD&C Act or for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public. Based on available evidence, FDA has concluded that the prohibition in section 301(ll) applies to CBD, as described above.

You should also be aware that, as defined in section 201(s) of the FD&C Act (21 U.S.C. 321(s)), the term “food additive” refers to any substance the intended use of which results in its becoming a component of any animal food, unless the substance is generally recognized as safe (GRAS) among qualified experts under the conditions of its intended use, or unless the substance meets a listed exception.3

There is no animal food additive regulation that authorizes the use of CBD. We are not aware of any information to indicate that CBD is the subject of a prior sanction (i.e., a sanction or approval granted prior to the enactment of the Food Additives Amendment of 1958 under the FD&C Act, the Poultry Products Inspection Act, or the Meat Inspection Act). Furthermore, we are not aware of any basis to conclude that CBD is GRAS for use in animal foods. FDA’s regulations in 21 CFR 570.30(a)-(c) describe the criteria for eligibility for classification of an animal food ingredient as GRAS. The use of an animal food substance may be GRAS based on either scientific procedures or, for a substance used in animal food before 1958, through experience based on common use in animal food (see 21 CFR 570.30). We know of no basis for general recognition of safety for CBD based either on scientific procedures or common use in animal food prior to January 1, 1958. Based on our review of the publicly available literature, the data and information necessary to support the safe use of CBD in animal foods are lacking. In fact, literature reports have raised safety concerns for animals consuming CBD, including, but not limited to, male reproductive toxicity and liver toxicity.

Therefore, based on our review, the use of CBD in animal products does not satisfy the criteria for GRAS status under 21 CFR 570.30.

Under section 409, an animal food additive is deemed unsafe unless it is approved by FDA for its intended use prior to marketing. CBD is not approved for use in any animal food. Animal food containing an unsafe food additive within the meaning of section 409 is adulterated within the meaning of section 402(a)(2)(C)(i) of the FD&C Act. Introduction of an adulterated animal food into interstate commerce is prohibited under section 301(a) of the FD&C Act, 21 U.S.C. 331(a).

The violations cited in this letter are not intended to be an all-inclusive statement of violations that exist in connection with your marketed products. You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your firm complies with all requirements of federal law, including FDA regulations.

You should take prompt action to correct the violations cited in this letter. Failure to promptly correct violations may result in legal action without further notice, including, without limitation, seizure and/or injunction.

Please notify FDA in writing, within fifteen working days of receipt of this letter, of the specific steps you have taken to correct these violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you believe that your products are not in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. If you cannot complete corrective action within fifteen working days, state the reason for the delay and the time within which you will complete the correction.

Your response should be sent to U.S. Food and Drug Administration, Center for Drug Evaluation and Research/Office of Compliance/Office of Unapproved Drugs and Labeling Compliance, 10903 New Hampshire Avenue, WO51, Silver Spring, MD 20993-0002 or by e-mail to [email protected]

Donald D. Ashley
Director
Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration

Eric Nelson
Director of Compliance
Office of Surveillance & Compliance
Center for Veterinary Medicine
Food and Drug Administration

William A. Correll Jr.
Director
Office of Compliance
Center for Food Safety and Applied Nutrition
Food and Drug Administration

1 CBD is the active ingredient in the approved drug product Epidiolex. Furthermore, the existence of substantial clinical investigations regarding CBD has been made public. For example, two such substantial clinical investigations include GW Pharmaceuticals’ investigations regarding Sativex and Epidiolex. (See Sativex Commences US Phase II/III Clinical Trial in Cancer Pain and GW Pharmaceuticals Receives Investigational New Drug (IND) from FDA for Phase 2/3 Clinical Trial of Epidiolex in the Treatment of Dravet Syndrome). FDA considers a substance to be “authorized for investigation as a new drug” if it is the subject of an Investigational New Drug application (IND) that has gone into effect. Under 21 CFR 312.2, unless a clinical investigation meets the limited criteria in that regulation, an IND is required for all clinical investigations of products that are subject to section 505 of the FD&C Act.

2 Under section 201(s) of the FD&C Act (21 U.S.C. 321(s)), the following types of substances are excluded from the food additive definition: (1) pesticide chemical residues in or on a raw agricultural commodity or processed food, (2) pesticide chemicals, (3) color additives, (4) substances used in accordance with a “prior sanction” (i.e., a sanction or approval granted prior to the enactment of the Food Additives Amendment of 1958 under the FD&C Act, the Poultry Products Inspection Act, or the Meat Inspection Act), (5) new animal drugs, and (6) dietary ingredients in or intended for use in a dietary supplement.

3 Under section 201(s)(5) of the FD&C Act (21 U.S.C. 321(s)(5)), new animal drugs are excluded from the food additive definition. If a new animal drug is unsafe within the meaning of section 512 because it is not approved for use in animal food, then the animal food is adulterated under section 402(a)(2)(C)(ii) of the FD&C Act.

See also  Can CBD Oil Cause Heart Palpitations

Infinite CBD Absolute Zero CBD Isolate

Infinite CBD uses one of two forms of CBD isolate to make their products. This is the raw form of CBD isolate they use to make most Infinite CBD products outside its Nano series. You can buy CBD isolates from a lot of companies, but rarely will you find them priced as low as Infinite CBD. This is one of the purest CBD isolates we’ve seen yet and comes at an incredibly low price of just $0.02 per milligram of CBD.

Infinite CBD is a top-notch CBD manufacturer in our books. They maintain strong integrity when it comes to manufacturing their products, and this isolate is no different. The company makes Absolute Zero using high-tech supercritical CO2 extraction — which means the company doesn’t need to use any solvents or other harmful ingredients.

They’re also one of the only companies we’ve seen offering the option for additional terpenes in their isolates. You can choose which terpenes are added to the mix to leverage more of an entourage effect than other isolates, and improve the flavor.

CBD isolates are only recommended for experienced users, but if you’re in the market for pure CBD at a decent price, look no further.

Price/Value 5/5

CBD isolates are almost always one of the least expensive ways to get your daily dose. Many competitors’ CBD isolates cost between $0.04 – $0.06 per mg of CBD. Infinite CBD undercuts the competition at $0.03 or less per mg of CBD. The company also allows you to add cannabis terpenes from 10 different strains — which isn’t seen very often with competitors. Absolute Zero provides a ton of value and lowers the cost to its customers.

CBD Potency 5/5

Infinite CBD’s Absolute Zero is more than 99% pure CBD extract. Although this is expected from CBD isolates, Infinite CBD offers the purity test results to back up its claims. If you’re looking for the highest possible CBD content, Infinite CBD is a great choice.

Hemp Source 4/5

Infinite CBD sources all of its hemp from a single organic farm in Colorado. Ordering from a single source and using CBD isolates allows Infinite CBD to ensure a greater level of consistency in the final product. The company also supplies third-party test results that confirm its extracts are free from heavy metals, pesticides, and mycotoxins. For the highest score, Infinite CBD should get its organic status certified.

Purpose/Uses 5/5

CBD isolates are by far one of the most versatile ways to use CBD. You can inhale them via dab rig or vaporizer, add them to your food or drink, or put them straight under your tongue. Infinite CBD gets full points here for giving you the option to add your choice of terpenes — which allows you to take advantage of the entourage effect.

Product Variations 5/5

When you account for the many sizes and 11 different flavor and terpene profiles, Infinite CBD’s Absolute Zero is available in 55 options. This is a massive selection that very few other suppliers can match.

Formulation/Ingredients 5/5

This CBD concentrate is the companies pure form of raw CBD. It scores 5 stars in this category because it’s one of the only CBD crystals we’ve seen with the option to add additional terpenes to the formula at the time of purchase.

By definition, a CBD concentrate is a pure form of CBD without any additional ingredients, but the option to add terpenes for added benefit is a great touch from Infinite CBD.

Product Variants

Infinite CBD
Infinite CBD Absolute Zero Isolate
1 Gram

4.83 / 5

Total CBD : ~990 mg
Potency : 99%
Cost per mg CBD : $0.03
Extract Type : CBD Isolate
Infinite CBD
Infinite CBD Absolute Zero Isolate
3.5 Grams

4.83 / 5

Total CBD : ~3465 mg
Potency : 99%
Cost per mg CBD : $0.03
Extract Type : CBD Isolate
$175.00
Infinite CBD
Infinite CBD Absolute Zero Isolate
7 Grams

4.83 / 5

Total CBD : ~6930 mg
Potency : 99%
Cost per mg CBD : $0.03
Extract Type : CBD Isolate
$345.00
Infinite CBD
Infinite CBD Absolute Zero Isolate
14 Grams

4.83 / 5

Total CBD : ~13,860 mg
Potency : 99%
Cost per mg CBD : $0.02
Extract Type : CBD Isolate
$670.00
Infinite CBD
Infinite CBD Absolute Zero Isolate
28 Grams

4.83 / 5

Total CBD : ~27,720 mg
Potency : 99%
Cost per mg CBD : $0.02
Extract Type : CBD Isolate
Table of Contents
  • Overview: Absolute Zero CBD Isolate
  • Key Features & Benefits

Infinite CBD Absolute Zero CBD Isolate Review

Article By

Isolates are one of the most versatile ways of using CBD. They’re available in a wide range of package sizes and can be inhaled or smoked, eaten, added to topicals, or mixed into other products to boost the CBD content.

If this is your first time looking at CBD isolates, they’re a pure CBD extract that comes in powder form. As the name implies, a CBD isolate involves separating the cannabinoid from all the other chemical compounds found in the cannabis plant (including the waxes, terpenes, and other cannabinoids like THC).

In the review, we’ll be examining Infinite CBD’s Absolute Zero CBD isolates. Infinite CBD is one of our preferred CBD suppliers because the company consistently manages to keep its prices low without sacrificing quality.

Overview: Absolute Zero CBD Isolate

Infinite CBD has a huge selection of products made from CBD isolate — which you can buy on its own. They call their CBD isolate “Absolute Zero.” This name is fitting, as it’s the purified baseline of their entire product line.

These CBD isolates come in a crystallized or powder-like form which makes it easy to alter your dose depending on how you feel day-to-day. Simply measure out the amount of CBD you think you’ll need then inhale it, add it to your drinks, food, or take it directly under the tongue.

Infinite CBD offers different sizes that range from a single gram all the way up to 28 grams. The larger the quantity you purchase, the more value you get.

Absolute Zero also gives you the option to add terpenes. Terpenes are plant compounds that add scents and flavors to the isolate. Terpenes may also help CBD do its job more effectively through a concept called the “entourage effect” or “plant synergy”. Learn more about the entourage effect here.

Depending on the package size you choose, Absolute Zero can be purchased from as low as $27.50 all the way to $703.50.

Pros & Cons

  • Huge Selection of Sizes
  • Option to add hemp-derived terpenes as well
  • Low-cost CBD option
  • THC-free
  • Doesn’t contain any additional cannabinoids
  • Requires extra care and attention to use safely and effectively

Key Features & Benefits

1. Huge Selection of Sizes

Benefit: Find the right amount of CBD for your routine

Infinite CBD’s Absolute Zero can be ordered in five sizes ranging from one gram all the way to 28 grams. If you translate this into CBD content it becomes 1000 to 28,000 mg. Whether you’re a heavy daily user or an infrequent user with mild symptoms, you should be able to find a package size that works for you and your budget.

2. Added Terpenes Available

Benefit: Terpenes can help CBD do its job even better

With Infinite CBD, you have the option of ordering your flavorless CBD isolate or you can choose between 10 unique cannabis plant terpene profiles. Terpenes add flavors to your CBD isolates and contribute to the entourage effect. Basically, when CBD is used with other chemical compounds found in cannabis, it may work better.

3. Inexpensive

Benefit: Spend less on your CBD extracts

Isolates are generally one of the least expensive ways to get your daily dose of CBD. This is especially true with Infinite CBD — many competitors’ CBD isolates cost around $0.04 – $0.06 per mg of CBD. Infinite CBD’s isolates start at $0.03 and get cheaper from there.

About The Company: Infinite CBD

Infinite CBD is a Colorado-based company that specializes in CBD isolates. The company claims to use CBD isolates over full-spectrum extracts in order to ensure a more consistent final product with a high CBD content.

Beyond CBD isolates, Infinite CBD offers a huge selection of unique items that you may not find elsewhere. Aside from tinctures, capsules, gummies, and isolates, you’ll also find lubricants, beard oils, hair masks, and antiseptic soap.

Infinite CBD also sponsors professional UFC fighters, cyclists, soccer players, and fitness competitors who claim that CBD is an essential part of their routine.